Olof Breuer

Article: BIOMEDICINES. 2023;11(2):295

Intravenous Infusion of High Dose Selenite in End-Stage Cancer Patients: Analysis of Systemic Exposure to Selenite and Seleno-Metabolites

Breuer O; Brodin O; Razaghi A; Brodin D; Gammelgaard B; Bjoernstedt M

Article: LANCET PSYCHIATRY. 2022;9(6):447-457

Improving lithium dose prediction using population pharmacokinetics and pharmacogenomics: a cohort genome-wide association study in Sweden

Millischer V; Matheson GJ; Bergen SE; Coombes BJ; Ponzer K; Wikstrom F; Jagiello K; Lundberg M; Stenvinkel P; Biernacka JM; Breuer O; Martinsson L; Landen M; Backlund L; Lavebratt C; Schalling M

Article: MYCOSES. 2022;65(1):79-87

Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?

Kurland S; Lowdin E; Furebring M; Shams A; Chryssanthou E; Lagerback P; Tangden T; Breuer O; Sjolin J

Article: JOURNAL OF LIPID RESEARCH. 2014;55(11):2408-2415

Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans

Bonde Y; Breuer O; Luetjohann D; Sjoberg S; Angelin B; Rudling M

Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69(3):467-475

VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation.

Marinova M; Lütjohann D; Breuer O; Kölsch H; Westhofen P; Watzka M; Mengel M; Stoffel-Wagner B; Hartmann G; Coch C; Oldenburg J

Article: JOURNAL OF PHARMACY AND PHARMACOLOGY. 2010;57(5):587-597

Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.

Fagerholm U; Breuer O; Swedmark S; Hoogstraate J

Article: ANESTHESIOLOGY. 2007;106(1):43-55

Pharmacokinetics of ropivacaine in patients with chronic end-stage liver disease

Jokinen MJ; Neuvonen PJ; Lindgren L; Hockerstedt K; Sjovall J; Breuer O; Askemark Y; Ahonen J; Olkkola KT

Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1997;272(48):30178-30184

Importance of a novel oxidative mechanism for elimination of brain cholesterol - Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with O-18(2) techniques in vivo and in vitro

Bjorkhem I; Lutjohann D; Breuer O; Sakinis A; Wennmalm A

Article: BIOCHEMICAL JOURNAL. 1997;323(Pt 3):853-858

Transformation of subcutaneous nitric oxide into nitrate in the rat

Benthin G; Bjorkhem I; Breuer O; Sakinis A; Wennmalm A

Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1996;93(18):9799-9804

Cholesterol homeostasis in human brain: Evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation

Lutjohann D; Breuer O; Ahlborg G; Nennesmo I; Siden A; Diczfalusy U; Bjorkhem I

Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1996;1302(2):145-152

The oxysterols cholest-5-ene-3 beta,4 alpha-diol, cholest-5-ene-3 beta,4 beta-diol and cholestane-3 beta,5 alpha,6 alpha-triol are formed during in vitro oxidation of low density lipoprotein, and are present in human atherosclerotic plaques

Breuer O; Dzeletovic S; Lund E; Diczfalusy U

Article: JOURNAL OF LIPID RESEARCH. 1995;36(11):2275-2281

IDENTIFICATION AND QUANTITATION OF CHOLEST-5-ENE-3-BETA,4-BETA-DIOL IN RAT-LIVER AND HUMAN PLASMA

BREUER O

Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1995;270(35):20278-20284

USE OF AN O-18(2) INHALATION TECHNIQUE AND MASS ISOTOPOMER DISTRIBUTION ANALYSIS TO STUDY OXYGENATION OF CHOLESTEROL IN RAT - EVIDENCE FOR IN-VIVO FORMATION OF 7-OXOCHOLESTEROL, 7-BETA-HYDROXYCHOLESTEROL, 24-HYDROXYCHOLESTEROL, AND 24-HYDROXYCHOLESTEROL

BREUER O; BJORKHEM I

Article: ANALYTICAL BIOCHEMISTRY. 1995;225(1):73-80

DETERMINATION OF CHOLESTEROL OXIDATION-PRODUCTS IN HUMAN PLASMA BY ISOTOPE-DILUTION MASS-SPECTROMETRY

DZELETOVIC S; BREUER O; LUND E; DICZFALUSY U

Articles

News from KI

Events from KI